ASX HLS: Why Lazard is betting on Healius despite ‘disappointing’ evidence

Australia News News

ASX HLS: Why Lazard is betting on Healius despite ‘disappointing’ evidence
Australia Latest News,Australia Headlines
  • 📰 FinancialReview
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 90%

The prospect of above-average returns is keeping the health tech company on the books, while Woodside and Santos still offer opportunity even at their higher prices.

Philipp Hofflin is portfolio manager of Lazard Asset Management’s Australian equity fund, based in Sydney. The firm oversees about $305.4 billion in assets.August results reported were overall in line with expectations, but management caution for the coming year led to net downgrades.

The operating cashflows for both companies over the next five years are expected to exceed their entire market capitalisation. This, for example, to undertake large investment programs to meet rising Asian demand for gas, as well as paying investors a dividend of over 6 per cent, fully franked. And while global investment in both new renewable and old sources of energy remains too low, the risks for energy prices are very much skewed to the upside.We bought into diagnostic imaging and pathology provider Healius on the expectation of a normalisation of GP visits and thus pathology volumes. Pathology and radiology companies have significant operating leverage, and any volume recovery would boost revenues and restore margins.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

FinancialReview /  🏆 2. in AU

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

ASX 200 LIVE: ASX to rise as global bond yields tumbleASX 200 LIVE: ASX to rise as global bond yields tumbleAustralian shares are set to open higher, tracking overseas markets. S&P 500 rises for third day. RBA’s Kent to speak near midday. Follow updates here.
Read more »

ASX 200 LIVE: ASX to rise as Wall Street sees Fed policymakers leaning towards a pauseASX 200 LIVE: ASX to rise as Wall Street sees Fed policymakers leaning towards a pauseFutures reversed losses after US policymakers signalled a more cautious policy stance; Birkenstock stumbles; Oil eases. Follow updates here.
Read more »

Before the Bell: ASX to rally, US bond yields tumble on bets rates at peakBefore the Bell: ASX to rally, US bond yields tumble on bets rates at peakAustralian shares are set to open higher, tracking overseas gains. Volatility eases. China seen ready for decisive growth boost.
Read more »

ASX has biggest gain in a monthASX has biggest gain in a monthThe Australian share market made its biggest one-day gain in a month, closing higher on Tuesday.
Read more »

ASX 200 ends the day up on TuesdayASX 200 ends the day up on TuesdayThe ASX 200 ended the day up on Tuesday by 1.01 per cent. According to Sky News Business Editor Ross Greenwood, the market had a “really good day today”. “With most sectors ahead led by utilities, IT companies and TELCOs,” he said. “Just drifted off a touch at the end but it did regain that key 7,000 mark. “The best performers today though were rebounds from recent losses.”
Read more »

ASX-aspirant Cuscal valued at as much as $736m: BofAASX-aspirant Cuscal valued at as much as $736m: BofABank of America research for IPO hopeful Cuscal Limited is out.
Read more »



Render Time: 2025-02-22 02:08:27